Reference
Caner B, et al. Hyperprogression and hypercalcemia after nivolumab treatment in three cases with renal cell carcinoma. Journal of Oncology Pharmacy Practice 28: 1645-1649, No. 7, Oct 2022. Available from: URL: http://doi.org/10.1177/10781552221077418
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1950, 44 (2023). https://doi.org/10.1007/s40278-023-36441-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-36441-9